Pharma Journalist 9038 posts 0 comments

Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research (Ludwig), Vaccitech Oncology Limited (VOLT), has entered into a clinical…
Read More...

Global Blood Therapeutics, Inc. and Syros Pharmaceuticals, Inc. announced that they have entered into a collaboration to discover, develop and commercialize novel therapies for sickle…
Read More...

Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut Technology, have announced a…
Read More...

Dicerna Pharmaceuticals, Inc. announced that the European Commission (EC) has granted orphan drug designation to Dicerna’s DCR-A1AT for the treatment of congenital alpha-1 antitrypsin…
Read More...

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and the Sean M.…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) voted 9-4 in favor…
Read More...

Shandong Fontacea Pharmaceutical Co. Ltd. announced that it has entered into an exclusive license, development and commercialization agreement with Janssen Biotech, Inc., to develop and…
Read More...

BioArctic AB (publ) announced the initiation of a research collaboration with Eisai aimed at further studying the unique profile of the investigational drug candidate BAN2401. The…
Read More...

Triplet Therapeutics, Inc., a biotechnology company harnessing human genetics to develop treatments for repeat expansion disorders at their source, launched today with $59 million in…
Read More...

CytoDyn Inc. and Vyera Pharmaceuticals, LLC announced that they have entered into a Commercialization and License Agreement (CLA) and a related Supply Agreement to commercialize…
Read More...